3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Mesothelioma, Malignant
5
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
pembrolizumab
9
Hyperthermic Intraperitoneal Chemotherapy
3
fludarabine
2
budigalimab
2
Nivolumab
2
Ipilimumab
2
Cytoreduction Surgical Procedures
2
Cyclophosphamide
2
Cisplatin
2
venetoclax
1
tocilizumab
1
tislelizumab
1
talazoparib
1
spartalizumab
1
sodium thiosulfate
1
rovalpituzumab tesirine
1
regorafenib
1
milademetan
1
irinotecan sucrosofate
1
fludarabine phosphate
1
epacadostat
1
entinostat
1
atezolizumab
1
X-Rays
1
Surgical Procedures, Operative
1
Specimen Handling
1
Sirolimus
1
Quality of Life
1
Polymerase Chain Reaction
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
sodium thiosulfate
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled